Between the Biotech Waves

Apr 08 2025 39 ep. 56 mins 15
Between the Biotech Waves Podcast artwork

Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.

  Science  Business
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Between the Biotech Waves - Sound Bite - Paul Matteis Equity Analyst Stifel

Apr 08 2025 26 mins  
Welcome to a Between the Biotech Waves sound bite, a short podcast to provide insight into the rapidly changing biotech environment - I am pleased to welcome Paul Matteis Managing Director, Head of Therapeutics Equity Research in Biotech at Stifel to discuss the current market dynamics affecting our biotech industry. RECORDED April 7th 2025

S2 E4: A Between the Biotech Waves Conversation with Dan Lynch

Feb 27 2025 61 mins  
In this episode, I am thrilled to welcome Dan Lynch, an Executive Venture Partner at Google Ventures and a seasoned leader in the biotechnology sector. Since joining GV in 2021, Dan has partnered with life sciences CEOs and executives, providing invaluable guidance as a trusted advisor and coach. His commitment to fostering long-term relationships underscores his belief that collab

S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder

Feb 20 2025 64 mins  
In today's episode, I am honored to welcome Stanley Crooke, the founder and CEO of Ionis Pharmaceuticals the first and leading antisense oligonucleotide biotech and founder, CEO and Chair of N-Lorem, a not for profit entity developing ASOs for ultra rare diseases. Stan is THE pioneer in the field of antisense oligonucleotide based RNA-targeted therapies. With a deep passion for sci

S2 E2: A Between the Biotech Waves Conversation with Peter Barrett

Jan 30 2025 53 mins  
Welcome to ‘Between the Biotech Waves,’ the podcast where we navigate the dynamic world of biotechnology and explore the minds driving its innovation. I’m your host, Nessan Bermingham, and today, we have a true visionary in the field, Peter Barrett. Peter is a partner at Atlas Venture, where he has been a key player in the creation of numerous novel therapeutic and drug disco

S2 Episode 1: A conversation with Matt Porteus

Jan 24 2025 54 mins  
Now that JPM '25 is behind us, where the weather was great but the mood was somber, back to podcasting! Welcome back to 'Between the Biotech Waves,' the podcast where we explore the frontiers of biotechnology and the remarkable individuals driving innovation. I’m your host, Nessan Bermingham, and today, we are honored to have Dr. Matt Porteus with us, a true pioneer in the field

Episode 35: A Between the Biotech Waves Conversation with Mike Curtis, President & CEO of eGenesis

Jul 02 2024 65 mins  
Welcome back to Between the Biotech Waves. I am sorry for the lack of episodes over the past few months, unfortunately life threw me a curve ball that I have been taking care of but now back and ready to go! Today it gives me great pleasure to introduce Mike Curtis, President and CEO of eGenesis. You may recall seeing eGenesis on the front cover of the New York Times recently follo

Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

Jul 18 2023 64 mins  
Today I am talking to Eliot Forster xCEO of F-star Therapeutics. Eliot was at helm of the company as they reversed merged into Springbank Pharmaceuticals & through the recently announced acquisition by Sino Biopharma, a transaction that generated a lot of interest given the very public interactions with CFIUS. Prior to F-star, Eliot was CEO of Immunocore, Creabilis and Solace P

Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.

Jul 18 2023 105 mins  
Today we have an unusual (& long) podcast where we talk to key members of the Triplet Therapeutics management team. Triplet was founded to develop antisense oligonucleotides targeting the DNA damage response pathway that has been implicated in driving repeat disorders including Huntington's disease - the lead indication for Triplet. The team discusses the challenges in building

Episode 31: A Between the Biotech Waves Conversation with Tim Yu

Jul 02 2023 55 mins  
Today we are talking to Tim Yu. Tim is attending physician at the division of genetics and genomics at Boston Children’s Hospital and assoc prof of Pediatrics at Harvard Medical School. The scope of work that Tim does is well beyond what can be covered in this intro however I have gotten to know Tim through his leading the emerging filed of N of 1 plus drugs. Tim worked with Juli

Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics

Jul 02 2023 45 mins  
Today we are talking to Barry Greene, CEO of Sage Therapeutics. Barry has had an amazing career spanning over 30 years in the biotech industry. Prior to Sage Barry was President of Alnylam shepherding it with John through its evolution from basic science through commercial product launch. Prior to ALNY Barry was general manager of Oncology at Millennium where he was directly involv